Cornerstone Investment Partners LLC Acquires 15,239 Shares of UnitedHealth Group Incorporated $UNH

Cornerstone Investment Partners LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 11.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 148,705 shares of the healthcare conglomerate’s stock after purchasing an additional 15,239 shares during the quarter. UnitedHealth Group comprises 2.0% of Cornerstone Investment Partners LLC’s holdings, making the stock its 27th biggest position. Cornerstone Investment Partners LLC’s holdings in UnitedHealth Group were worth $46,391,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Glass Jacobson Investment Advisors llc grew its holdings in shares of UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 55 shares in the last quarter. Kentucky Trust Co lifted its stake in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Finally, Nova Wealth Management Inc. grew its stake in shares of UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after acquiring an additional 78 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on UNH shares. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Jefferies Financial Group boosted their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a report on Friday, October 17th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Down 1.8%

UNH stock opened at $321.68 on Friday. The business’s 50 day simple moving average is $345.55 and its 200 day simple moving average is $324.07. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $291.39 billion, a PE ratio of 16.79, a PEG ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the company earned $7.15 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.